E-DRUG: ARVs for low income countries: analysis of commercial viability (2)
---------------------------------------------------------------------------
Dear Olive Nakakeeto and Brian Elliott,
Great work. Thanks for alert.
Hope those concerned with vaccine procurement are sensitive to this pricing issue and are reading.
All pharmaceutical industries survive for making profits. Let us hope that they make reasonable profits and do not indulge in profiteering.
regards
Dr Vijay Thawani,
India
vijaythawani@rediffmail.com